FDA Calendar
Returns FDA calendar data with filtering options.
The FDA calendar contains information about:
- PDUFA (Prescription Drug User Fee Act) dates
- Advisory Committee Meetings
- FDA Decisions
- Clinical Trial Results
- New Drug Applications
- Biologics License Applications
Date Format Support
The target_date parameters support various FDA-specific date formats:
- Quarters: YYYY-Q[1-4] (e.g. 2024-Q1)
- Half years: YYYY-H[1-2] (e.g. 2024-H1)
- Mid-year: YYYY-MID (e.g. 2024-MID)
- Late-year: YYYY-LATE (e.g. 2024-LATE)
- Standard dates: YYYY-MM-DD
Authorizations
Bearer authentication header of the form Bearer <token>, where <token> is your auth token.
Query Parameters
Minimum announced date (YYYY-MM-DD) A trading date in the format of YYYY-MM-DD. This is optional and by default the last trading date.
"2024-01-18T00:00:00.000Z"
Maximum announced date (YYYY-MM-DD) A trading date in the format of YYYY-MM-DD. This is optional and by default the last trading date.
"2024-01-18T00:00:00.000Z"
Minimum target date (supports Q1-Q4, H1-H2, MID, LATE formats) FDA target date in one of the following formats:
- YYYY-Q[1-4] (e.g. 2024-Q1)
- YYYY-H[1-2] (e.g. 2024-H1)
- YYYY-MID (e.g. 2024-MID)
- YYYY-LATE (e.g. 2024-LATE)
- YYYY-MM-DD
^\d{4}-(Q[1-4]|H[1-2]|MID|LATE|\d{2}-\d{2})$"2024-Q1"
Maximum target date (supports Q1-Q4, H1-H2, MID, LATE formats) FDA target date in one of the following formats:
- YYYY-Q[1-4] (e.g. 2024-Q1)
- YYYY-H[1-2] (e.g. 2024-H1)
- YYYY-MID (e.g. 2024-MID)
- YYYY-LATE (e.g. 2024-LATE)
- YYYY-MM-DD
^\d{4}-(Q[1-4]|H[1-2]|MID|LATE|\d{2}-\d{2})$"2024-Q1"
Filter by drug name (partial match) Drug name to filter FDA calendar entries (partial match supported)
"Keytruda"
Filter by ticker symbol
A comma separated list of tickers. To exclude certain tickers prefix the first ticker with a -.
"AAPL,INTC"
Maximum number of results to return. Defaults to 100. Values above 500 are clamped to 500.
1 <= x <= 500Response
FDA Calendar response
FDA calendar events with company information
Name of the drug under FDA review
"Lifileucel"
The end date of the FDA event
"2024-02-24T00:00:00.000Z"
The start date of the FDA event
"2024-02-24T00:00:00.000Z"
The current status of the FDA application (e.g., NDA, BLA)
"NDA"
The ticker of the company applying for drug admission.
"IOVA"
The type of FDA event (e.g., PDUFA Date, Advisory Committee Meeting)
"PDUFA Date"
Detailed description of the FDA event
"FDA decision for Lifileucel in advanced melanoma"
Whether the company has options available for trading
true
The medical condition the drug is intended to treat
"Advanced Melanoma"
The company's market capitalization in USD
"1000000000"
Additional important notes about the FDA event
"Important milestone for the company's drug pipeline"
The outcome of the FDA event if already occurred
"Approved"
Brief summary of the FDA event outcome
"Complete Response Letter received"
Link to the source of the FDA event information
"https://www.fda.gov/news-events/press-announcements/fda-example"
